265 related articles for article (PubMed ID: 25374221)
1. Adjuvant radiotherapy for gastric carcinoma: 10 years follow-up of 244 cases from a single institution.
Misirlioglu HC; Coskun-Breuneval M; Kucukpilakci B; Ugur VI; Elgin Y; Demirkasimoglu T; Kara SP; Ozgen A; Sanri E; Guney Y
Asian Pac J Cancer Prev; 2014; 15(20):8871-6. PubMed ID: 25374221
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis.
Stumpf PK; Amini A; Jones BL; Koshy M; Sher DJ; Lieu CH; Schefter TE; Goodman KA; Rusthoven CG
Cancer; 2017 Sep; 123(17):3402-3409. PubMed ID: 28513823
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemoradiotherapy after D2 resection in gastric cancer: a single-center observational study.
Kaytan Saglam E; Yucel S; Balik E; Saglam S; Asoglu O; Yamaner S; Bugra D; Oral EN; Kizir A; Kapran Y; Sakar B; Akyuz A; Gulluoglu M
J Cancer Res Clin Oncol; 2015 Feb; 141(2):361-7. PubMed ID: 25189794
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.
Fu S; Lu JJ; Zhang Q; Yang Z; Peng L; Xiong F
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1488-94. PubMed ID: 18538489
[TBL] [Abstract][Full Text] [Related]
6. Postoperative chemoradiation in patients with localized gastric adenocarcinoma: single center experience.
Yoney A; Bati Y; Isikli L; Unsal M
Indian J Cancer; 2011; 48(1):24-30. PubMed ID: 21248450
[TBL] [Abstract][Full Text] [Related]
7. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
[TBL] [Abstract][Full Text] [Related]
8. The management of gastric adenocarcinoma with postoperative chemoirradiation. A non-randomized comparison of oral UFT and 5-FU.
Surenkok S; Beyzadeoglu M; Oysul K; Ozyigit G; Ataergin S; Arpaci F; Ozet A
Tumori; 2008; 94(1):70-4. PubMed ID: 18468338
[TBL] [Abstract][Full Text] [Related]
9. Prognostic analysis of patients with operable gastric cancer and tolerability to adjuvant radio-chemo-therapy.
Kucukoner M; Arpaci E; Isikdogan A; Bilici M; Uncu D; Cetin B; Dane F; Inanc M; Ekinci AS; Inal A; Cayir K; Yetisyigit T; Ozdemir N; Kaplan MA; Aksoy S; Alkıs N; Tekin SB; Eroglu C; Turhal S; Buyukberber S
Neoplasma; 2013; 60(1):19-25. PubMed ID: 23067212
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer.
Shi C; Yang B; Chen Q; Yang J; Fan N
Oncology; 2011; 80(5-6):289-95. PubMed ID: 21778768
[TBL] [Abstract][Full Text] [Related]
11. A phase II trial of concurrent 3D-CRT/IMRT and oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) in gastric cancer patients with R0 gastrectomy and D2 lymph node dissection.
Wang X; Shen Y; Zhu H; Zhao Y; Li Z; Qiu M; Li Q; Gou H; Yang Y; Cao D; Liu J; Yi C; Liao Z; Luo D; Bi F; Xu F
Gastric Cancer; 2016 Jan; 19(1):245-54. PubMed ID: 25609451
[TBL] [Abstract][Full Text] [Related]
12. Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view.
Lim DH; Kim DY; Kang MK; Kim YI; Kang WK; Park CK; Kim S; Noh JH; Joh JW; Choi SH; Sohn TS; Heo JS; Park CH; Park JO; Lee JE; Park YJ; Nam HR; Park W; Ahn YC; Huh SJ
Br J Cancer; 2004 Jul; 91(1):11-7. PubMed ID: 15162146
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemoradiation in gastric cancer: long-term outcomes and prognostic factors from a single institution.
Bruixola G; Segura Á; Díaz-Beveridge R; Caballero J; Bennis MH; Palomar L; Giménez A; Mingol F; García-Mora C; Aparicio J
Tumori; 2015; 101(5):517-23. PubMed ID: 26045120
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemoradiotherapy with or without intraoperative radiotherapy for the treatment of resectable locally advanced gastric adenocarcinoma.
Zhang Q; Tey J; Peng L; Yang Z; Xiong F; Jiang R; Liu T; Fu S; Lu JJ
Radiother Oncol; 2012 Jan; 102(1):51-5. PubMed ID: 22178689
[TBL] [Abstract][Full Text] [Related]
15. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
An MS; Yoo JH; Kim KH; Bae KB; Choi CS; Hwang JW; Kim JH; Kim BM; Kang MS; Oh MK; Hong KH
World J Surg Oncol; 2015 Feb; 13():64. PubMed ID: 25889520
[TBL] [Abstract][Full Text] [Related]
16. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of an R1 resection in gastric cancer patients treated with adjuvant chemoradiotherapy.
Stiekema J; Trip AK; Jansen EP; Boot H; Cats A; Ponz OB; Verheij M; van Sandick JW
Ann Surg Oncol; 2014 Apr; 21(4):1107-14. PubMed ID: 24306660
[TBL] [Abstract][Full Text] [Related]
18. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.
Kim S; Lim DH; Lee J; Kang WK; MacDonald JS; Park CH; Park SH; Lee SH; Kim K; Park JO; Kim WS; Jung CW; Park YS; Im YH; Sohn TS; Noh JH; Heo JS; Kim YI; Park CK; Park K
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1279-85. PubMed ID: 16099596
[TBL] [Abstract][Full Text] [Related]
19. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.
Dikken JL; Jansen EP; Cats A; Bakker B; Hartgrink HH; Kranenbarg EM; Boot H; Putter H; Peeters KC; van de Velde CJ; Verheij M
J Clin Oncol; 2010 May; 28(14):2430-6. PubMed ID: 20368551
[TBL] [Abstract][Full Text] [Related]
20. Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer.
Park HS; Jung M; Kim HS; Kim HI; An JY; Cheong JH; Hyung WJ; Noh SH; Kim YI; Chung HC; Rha SY
Ann Surg Oncol; 2015 Jan; 22(1):224-31. PubMed ID: 25081339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
